Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Central remyelination restores secure conduction.
Unilateral internuclear ophthalmoplegia after minor head injury.
The Advances in Neurobiology.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Therapy of NMO spectrum disorders.
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
CNS myelin structural modification induced in vitro by phospholipases A2.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Transdermal immunotherapy: Past, present and future.
Highly polarized Th17 cells induce EAE via a T-bet-independent mechanism.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
Antibody therapies in CNS diseases.
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Deep morphea induced by interferon-β1b injection.
Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms).
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »